Timothy Lu

338 posts

Timothy Lu

Timothy Lu

@timlu

Synthetic Biologist | Biotech Entrepreneur | MIT Professor

Katılım Nisan 2007
793 Takip Edilen4.7K Takipçiler
Timothy Lu retweetledi
Senti Biosciences
Senti Biosciences@SentiBio·
Dr. Kanya Rajangam, Chief Medical Officer, emphasized that the encouraging SENTI-202 data support advancement into pivotal studies and exploration across additional patient populations, enabled by recent RMAT and Orphan Drug Designations. bit.ly/3XFf7ST $SNTI #ASH2025
Senti Biosciences tweet media
English
1
2
2
1.2K
Timothy Lu
Timothy Lu@timlu·
$SNTI recently reported our Logic Gated SENTI-202 cell therapy achieved 50% ORR, 42% CR/CRh, 7.6 month cCR durability in heavily pretreated refractory/refractory AML patients at #ASH25. This is an exciting new treatment modality for R/R AML, a disease with a median OS ~5 months
Senti Biosciences@SentiBio

Dr. Nosha Farhadfar noted that SENTI-202 is demonstrating deep, durable responses and a favorable safety profile in R/R AML, underscoring its potential to selectively target AML cells while preserving healthy ones. bit.ly/3XFf7ST $SNTI #AML #ASH2025

English
5
2
4
1K
Timothy Lu
Timothy Lu@timlu·
@drpatrick @BillOReilly @drpatrick I agree with the power of NK cells. @SentiBio just presented exciting data at #ASH2025 showing that SENTI-202 Logic Gated CAR-NK cells are able to generate deep, durable responses in relapsed/refractory AML with a well tolerated safety profile
English
1
0
0
135
Dr. Pat Soon-Shiong
Dr. Pat Soon-Shiong@DrPatrick·
Thank you @BillOReilly for making your audience aware of the power of natural killer (NK) cells. The first responder against cancer. The show will air on Tuesday and on Thanksgiving day.
Bill O'Reilly@BillOReilly

What if everything we thought we knew about cancer was wrong? @ChrisCuomo sits down with @drpatrick on a breakthrough that will astound you — “Killing Cancer” Tuesday, November 25, at 10p/9C only on NewsNation. To find NewsNation on your screen: NewsNationNow.com

English
28
248
1.3K
61.3K
Timothy Lu
Timothy Lu@timlu·
@AACR @SarahCannonDocs Thank you to Dr. Strickland for presenting @SentiBio's SENTI-202 program at #AACR25 yesterday. We're excited to continue advancing our Logic Gated cell therapies for difficult cancers! $SNTI
English
0
0
3
126
AACR
AACR@AACR·
SENTI-202, an off-the-shelf, logic-gated, CAR natural killer cell therapy drove complete remission of pretreated blood cancers in a first-in-human trial, according to results presented by Stephen Strickland Jr., MD, MSCI: aacr.org/about-the-aacr… #AACR25 @SarahCannonDocs
AACR tweet media
English
1
4
6
2.8K
Timothy Lu
Timothy Lu@timlu·
Excited to share updates on Senti Bio’s SENTI-202 program with Positive Preliminary Clinical Results in the Treatment of Patients with Relapsed/Refractory AML. Come join us at 830 AM ET webinar! $SNTI investors.sentibio.com/news-releases/…
English
2
1
9
1.4K
Jorge Ortiz
Jorge Ortiz@jortiz81·
Tenured 🥂
English
7
0
66
4.7K
Timothy Lu retweetledi
Senti Biosciences
Senti Biosciences@SentiBio·
Kanya Rajangam, MD, PhD, President and Chief Medical Officer of $SNTI, shares her excitement for the upcoming data presentation from the SENTI-202 trial at the AACR Annual Meeting being held April 25-30, 2025 bit.ly/3QYtOx5 @AACR
Senti Biosciences tweet media
English
291
609
5.7K
9.7M
Timothy Lu retweetledi
Senti Biosciences
Senti Biosciences@SentiBio·
Senti Bio to Showcase SENTI-202 Clinical Data and Novel Logic Gated Gene Circuit Mechanism of Action in Oral and Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025 bit.ly/3QYtOx5 $SNTI #CellTherapy #CARNK @AACR #AACR25
Senti Biosciences tweet media
English
295
565
5K
11.4M
Timothy Lu
Timothy Lu@timlu·
Very excited to share details on SENTI-202 clinical trial - 2 of 3 pts achieved MRD negative CR in 1st dose level evaluated with a generally well-tolerated preliminary safety profile. Both patients continue to maintain remission (4+ and 3+ months, respectively). $SNTI
Senti Biosciences@SentiBio

Today, we announced positive initial clinical data from the Phase 1 trial of SENTI-202, a potential first-in-class, off-the-shelf #CARNK #celltherapy for R/R hematologic malignancies, including #AML. Learn more on our webcast on Dec. 3 at 7:30am ET: bit.ly/4eUaKtb $SNTI

English
0
1
12
2.3K
Timothy Lu
Timothy Lu@timlu·
Excited to share the detailed data on SENTI-202 with Dr. Stephen Strickland and Dr. Kanya Rajangam. Join us to learn about how our #genecircuits enhanced CAR-NK therapies have the potential to transform the treatment of cancer through Logic Gating. $SNTI
Senti Biosciences@SentiBio

Join us for a live webcast where Senti management and Dr. Stephen Strickland will discuss the positive initial clinical data from the Phase 1 clinical trial of SENTI-202, a Logic-Gated, selective CD33/FLT3-targeting #CARNK #celltherapy. Access here: bit.ly/4eUaKtb $SNTI

English
1
1
10
2.2K
Timothy Lu retweetledi
Senti Biosciences
Senti Biosciences@SentiBio·
Join us for a live webcast where Senti management and Dr. Stephen Strickland will discuss the positive initial clinical data from the Phase 1 clinical trial of SENTI-202, a Logic-Gated, selective CD33/FLT3-targeting #CARNK #celltherapy. Access here: bit.ly/4eUaKtb $SNTI
Senti Biosciences tweet media
English
1
2
12
3.8K
Timothy Lu
Timothy Lu@timlu·
Congratulations to @SentiBio for its $8M award from California Institute for Regenerative Medicine (CIRM) for its Logic-Gated SENTI-202 clinical trial for relapsed/refractory AML. Thanks so much to CIRM for this support! $SNTI cirm.ca.gov/about-cirm/new…
English
1
0
14
1.3K
Timothy Lu
Timothy Lu@timlu·
Check out how $SNTI's Logic Gates precisely discriminate between cancer cells and healthy cells, allowing us to achieve highly precise cancer therapeutics! #synbio
Senti Biosciences@SentiBio

At Senti, we envision a world where #cancer patients can access smarter therapies that precisely kill their cancer cells and spare their healthy cells. Watch to learn how we're utilizing our proprietary Logic Gating technology to design #CARNK cell therapies to achieve this goal.

English
1
1
10
3.7K

Keşfet

@MDAndersonNews @VJHemOnc @GeneOnlineNews @SentiBio @drpatrick @BillOReilly @AACR @SarahCannonDocs